MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Facial expressivity in Parkinson’s disease (PD) via an examination of smiling behavior: Preliminary findings

    D.L. McCabe, A.D. Bono, R.J. Stafford, A.I. Dumer, K.A. Scorpio, J.L. Spielman, R. Bind, L.O. Ramig, J.C. Borod (New York, NY, USA)

    Objective: The purpose was to examine facial emotional expression in individuals with PD and in healthy control (HC) subjects (Ss) using the Facial Action Coding…
  • 2016 International Congress

    Coping styles and their influence on outcomes in Parkinson’s disease

    K.M. Sundvick, F. Kassam, N. Dispirito, E. Book, S. Cresswell (Vancovuer, BC, Canada)

    Objective: To understand the associations between coping styles and various clinical symptoms and outcomes in patients with Parkinson's disease (PD). Background: The diagnosis of a…
  • 2016 International Congress

    A case of misdiagnosed Parkinson’s disease (PD)

    I. Gabrielyan, K. Harutyunyan, G. Avagyan, H. Amirjanyan, A. Voskanyan, S. Khachaturyan, H. Hambardzumyan, A. Nazaryan, H. Manvelyan (Yerevan, Armenia)

    Objective: Parkinson's disease (PD) is a neurodegenerative disorder affecting the basal ganglia. Parkinsonism is the main syndrome of PD, characterised by bradykinesia, rigidity, rest tremor…
  • 2016 International Congress

    Objective, unobtrusive assessment of bradykinesia in Parkinson’s disease

    P.J.M. Bank, J. Marinus, J.H. de Groot, C.G.M. Meskers, J.J. van Hilten (Leiden, Netherlands)

    Objective: To evaluate unobtrusive motion tracking for objective assessment of bradykinesia of the upper extremity in Parkinson's disease (PD). Background: The MDS-UPDRS is the most…
  • 2016 International Congress

    Clinical and instrumental gait analysis study of fear of falling in Parkinson’s disease patients

    P.C. Gordon, J.B. Ferraz, L.M. Medeiros, L.F.R. Oliveira, D.K. Amado, A.M. Lima Neto, M.S.G. Rocha (Sao Paulo, Brazil)

    Objective: Our aim is to analyze the fear of falling in patients with PD through both clinical variables and instrumented analysis of movement and gait.…
  • 2016 International Congress

    Patient reported outcomes in Parkinson’s disease (PRO-PD) rating scale validation

    L.K. Mischley (Kenmore, WA, USA)

    Objective: To evaluate whether a novel outcome measure, Patient-Reported Outcomes in Parkinson's disease (PRO-PD), correlates with disease duration, quality of life and established measures of…
  • 2016 International Congress

    An update on genotype-phenotype correlation in X-linked dystonia-parkinsonism (XDP/DYT3)

    M.E. Dy, C.M. De Gusmao, M.E. Talkowski, T.J. Multhaupt-Buell, L.R. Paul, C. Bragg, N. Sharma (Boston, MA, USA)

    Objective: To further characterize the severity, movement abnormalities, and disease course in an expanded cohort of subjects and their families with XDP and determine if…
  • 2016 International Congress

    Phenomenology of idiopathic adult-onset truncal dystonia

    D.J. Ehrlich, S.J. Frucht (New York, NY, USA)

    Objective: Characterize the phenomenology and natural history of adult onset idiopathic truncal dystonia. Background: Focal dystonias are the most common type of adult-onset dystonia, however,…
  • 2016 International Congress

    Experience of pallidal deep brain stimulation (DBS) in dystonia at a tertiary care centre in India

    D. Srinivas, R. Yadav, K. Jhunjhunwala, P. Pal (Bangalore, India)

    Objective: The therapeutic role of Deep Brain Stimulation (DBS) has expanded for severe primary and secondary dystonias. Till date, only a few centres in India…
  • 2016 International Congress

    Predictors of onabotulinumtoxinA treatment response in patients with cervical dystonia

    J. Jankovic, S. Marc, A. Aubrey (Houston, TX, USA)

    Objective: Data from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy), an observational, multicenter, prospective clinical registry, were analyzed to try to…
  • « Previous Page
  • 1
  • …
  • 47
  • 48
  • 49
  • 50
  • 51
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley